Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

By afschroeder • November 4, 2025

Moore HP, Fogel JM, Marzinke MA, Halvas EK, Parikh UM, Mellors JW, Penrose KJ, Seisa M, Petropoulos C, Price AL, Moser A, Wang Z, McCauley M, Valencia-Huamaní J, Rinehart AR, Rooney JF, Soto-Torres L, Grinsztejn B, Landovitz RJ, Eshleman SH. Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083. Open Forum Infect Dis. 2025 Oct 15;12(11):ofaf645. doi: 10.1093/ofid/ofaf645. PMID: 41180007; PMCID: PMC12575077.

Tags: Drug resistance, HIV, Infectious Diseases, INSTI, Publications, TLD, transmitted

Development of a feasible and portable electronic flag for near-real-time identification of renal replacement therapy in the Veterans Health Administration

Golenbock SW, Basnet D, Mull HJ, Lamkin R, Harvey K, Shin M, Strymish JM, Leatherman S, Ferguson R, Branch-Elliman W. Development of a feasible and[...]

Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis

García-Sarreón A, Martinez-Lopez Y, Gómez-Figueroa E, Rivas-Alonso V, Flores J, Behne JM, Yeaman MR, Smith TJ, Behne MK, Delgado-Garcia G, Corona T. Patient-reported quality of[...]

Study protocol to evaluate an integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH: an open-label, usual care-controlled, randomized trial

Liu H, Shen J, Wang Y, Carnes TC, Hamilton AB, Witt MD, Daar ES. Study protocol to evaluate an integrated intervention using a pill ingestible[...]